JOSE BAEZ: Open Payments
NPI 1336103233 · LAWRENCE, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,684 in 252 payments from 34 companies in 2025. Trend: 2023 $4,212 · 2024 $3,694 · 2025 $5,684
Food & beverage: $5,680Education: $4
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 56 | $1,182 |
| AstraZeneca Pharmaceuticals LP | 34 | $819 |
| Phathom Pharmaceuticals, Inc. | 14 | $313 |
| Corcept Therapeutics | 9 | $307 |
| Bayer Healthcare Pharmaceuticals Inc. | 12 | $276 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $245 |
| PFIZER INC. | 12 | $238 |
| Amgen Inc. | 8 | $205 |
| Novo Nordisk Inc | 7 | $199 |
| Lilly USA, LLC | 7 | $172 |
Products named: FARXIGA, VRAYLAR, LINZESS, VOQUEZNA, Korlym, Kerendia, CAPLYTA, EVENITY.
Industry payments across MA — which companies pay providers there.
